Our expansive research facilities, state-of-the-art technologies and unique location within The Royal Children’s Hospital, are some of the reasons we’re home to over 1,800 leading researchers and scientists.
Stay informed with the latest research insights, technological advancements and innovations in child health from our research and scientific community.
Discover how you can support us and our partners to help our researchers make life-changing breakthroughs for children.
Search throughout the entire MCRI website to find exactly what you are looking for.
Neurofibromatosis type 1 is a genetic condition arising from a gene mutation that causes tumours to grow on nerve tissue. The nerve tumours are usually non-cancerous (benign).
Speaking, reading and writing are vital for communicating, learning, participating and socialising. Exposure in infancy to talking, reading and singing lays the foundation for life.
Australian researchers are at the forefront of a new clinical trial that may bring hope to children with Duchenne muscular dystrophy (DMD) and their families. The phase II trial, funded by Antisense Therapeutics, will test a potential new drug for DMD in children who have become wheelchair-bound
Improving emergency care for children through research and national and international collaboration.
Children with cancer and blood disorders, their families and healthcare workers across Australia are invited to participate in a world-first global survey that will shape the future of research into bone marrow transplants. The Bone Marrow Transplantation in Paediatrics Priority Partnership, an
A new online tool has been launched to support expectant parents in their choices around prenatal testing for chromosome conditions in their unborn baby. It’s YourChoice, created by the Murdoch Children’s Research Institute and James Cook University, aims to guide pregnant women through the
A Murdoch Children’s Research Institute (MCRI)-led project to further develop personalised concussion care for children and young people has received federal funding. Professor Vicki Anderson has been awarded a $1.5 million Traumatic Brain Injury grant by the Medical Research Future Fund
Murdoch Children's Research Institute (MCRI) and Incepta Pharmaceuticals, based in Bangladesh, have embarked on a collaboration aimed at bringing life-saving innovation to the global healthcare landscape. MCRI has announced the signing of a non-exclusive licensing agreement with Incepta
The Murdoch Children’s Research Institute has welcomed the news that children born with the most common form of dwarfism, achondroplasia, will have access to a new life-changing treatment on the Pharmaceutical Benefits Scheme (PBS). The Federal Government this week listed Voxzogo (vosoritide),
In the past ten years or so there has been a lot of interest to see if medicinal cannabis can help children with emotional and behavioural problems – the ones associated with conditions such as autism, ADHD (attention-deficit hyperactivity disorder) and Tourette syndrome. Australia’s drug
Page 128 of 188
